RxDoctor Payments Data

Howland Crosswell, MD

Pediatric Hematology-Oncology · Greenville, SCNPI 1811943871

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.8%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Servier Pharmaceuticals LLC at 25.6% of the total. Reporting peaked in 2022 at $5,898 and has fallen 77.5% since, to $1,326 in 2024.

$14,371in general payments, 2019–2025

Across 57 payments — averaging $252.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Servier Pharmaceuticals LLC$4K
  • Jazz Pharmaceuticals Inc.$4K
  • Seagen Inc.$2K
  • Pharmacosmos Therapeutics Inc.$2K
  • Adaptive Biotechnologies Corporation$1K
  • E.r. Squibb & Sons, L.L.C.$946
  • plus $1K from 20 others
$469,225in research payments, 2019–2025

Across 92 payments — averaging $5100.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$266K
  • Seagen Inc.$80K
  • Takeda Pharmaceuticals U.S.A., Inc.$69K
  • Gilead$41K
  • Adaptive Biotechnologies Corporation$14K

What the payments were for

  • Consulting fees$7,44152%
  • Speaking & faculty fees$4,61532%
  • Travel & lodging$3292%
  • Food & beverage$1,98614%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,371 in reported general payments places this provider in the 80th percentile of 32 pediatric hematology-oncology providers in South Carolina.

See all pediatric hematology-oncology providers in South Carolina

Medicare billing

Part B allowed, 2024
$7,513
Medicare patients
22
Services billed
53

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levothyroxine Sodium30$422
Oxycodone Hcl12$245
Promethazine Hcl11$113

Paid to pharmacies, not to this prescriber.

Other pediatric hematology-oncology in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →